Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Walters

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Ophthalmology|January 1, 1997
Brimonidine tartrate: a one-month dose response studyR J Derick, A L Robin, T R Walters, et al.
Schizophrenia Research|May 6, 2018
Premature mortality among people with severe mental illness - New evidence from linked primary care dataAnn John, Joanna McGregor, Ian Jones, et al.
Schizophrenia Bulletin|June 21, 2019
Oscillatory, Computational, and Behavioral Evidence for Impaired GABAergic Inhibition in SchizophreniaAlexander D Shaw, Laura Knight, Tom C A Freeman, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 9, 2017
Childhood cognitive development in 22q11.2 deletion syndrome: case-control studySamuel J R A Chawner, Joanne L Doherty, Hayley Moss, et al.
Schizophrenia Research|February 19, 2014
Further evidence for high rates of schizophrenia in 22q11.2 deletion syndromeStephen Monks, Maria Niarchou, Aimée R Davies, et al.
Translational Psychiatry|April 22, 2024
Common risk alleles for schizophrenia within the major histocompatibility complex predict white matter microstructureXavier Caseras, Emily Simmonds, Antonio F Pardiñas, et al.
Schizophrenia Bulletin|June 8, 2022
Schizophrenia Polygenic Risk and Experiences of Childhood Adversity: A Systematic Review and Meta-analysisGrace E Woolway, Sophie E Smart, Amy J Lynham, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2024
Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophreniaDjenifer B Kappel, Elliott Rees, Eilidh Fenner, et al.
Biological Psychiatry|October 25, 2016
Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank SubjectsKimberley M Kendall, Elliott Rees, Valentina Escott-Price, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 16, 2019
Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK BiobankKimberley M Kendall, Matthew Bracher-Smith, Harry Fitzpatrick, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Ophthalmology|January 1, 1997
Brimonidine tartrate: a one-month dose response studyR J Derick, A L Robin, T R Walters, et al.
Schizophrenia Research|May 6, 2018
Premature mortality among people with severe mental illness - New evidence from linked primary care dataAnn John, Joanna McGregor, Ian Jones, et al.
Schizophrenia Bulletin|June 21, 2019
Oscillatory, Computational, and Behavioral Evidence for Impaired GABAergic Inhibition in SchizophreniaAlexander D Shaw, Laura Knight, Tom C A Freeman, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 9, 2017
Childhood cognitive development in 22q11.2 deletion syndrome: case-control studySamuel J R A Chawner, Joanne L Doherty, Hayley Moss, et al.
Schizophrenia Research|February 19, 2014
Further evidence for high rates of schizophrenia in 22q11.2 deletion syndromeStephen Monks, Maria Niarchou, Aimée R Davies, et al.
Translational Psychiatry|April 22, 2024
Common risk alleles for schizophrenia within the major histocompatibility complex predict white matter microstructureXavier Caseras, Emily Simmonds, Antonio F Pardiñas, et al.
Schizophrenia Bulletin|June 8, 2022
Schizophrenia Polygenic Risk and Experiences of Childhood Adversity: A Systematic Review and Meta-analysisGrace E Woolway, Sophie E Smart, Amy J Lynham, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2024
Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophreniaDjenifer B Kappel, Elliott Rees, Eilidh Fenner, et al.
Biological Psychiatry|October 25, 2016
Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank SubjectsKimberley M Kendall, Elliott Rees, Valentina Escott-Price, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 16, 2019
Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK BiobankKimberley M Kendall, Matthew Bracher-Smith, Harry Fitzpatrick, et al.
Pageof 19